Advertisement

More articles from Erratum

You have access
Correction to “Glutathione S-Transferase P Influences Redox Homeostasis and Response to Drugs that Induce the Unfolded Protein Response in Zebrafish”
Journal of Pharmacology and Experimental Therapeutics April 2021, 377 (1) 199; DOI: https://doi.org/10.1124/jpet.120.000417err
You have access
Correction to “A Novel Mitochondrial Complex of Aldosterone Synthase, Steroidogenic Acute Regulatory Protein, and Tom22 Synthesizes Aldosterone in the Rat Heart”
Journal of Pharmacology and Experimental Therapeutics April 2021, 377 (1) 200; DOI: https://doi.org/10.1124/jpet.120.000365err
You have access
Correction to “Specific Lowering of Asymmetric Dimethylarginine by Pharmacological Dimethylarginine Dimethylaminohydrolase Improves Endothelial Function, Reduces Blood Pressure and Ischemia-Reperfusion Injury”
Journal of Pharmacology and Experimental Therapeutics March 2021, 376 (3) 463; DOI: https://doi.org/10.1124/jpet.120.000212err
You have access
Correction to “Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor”
Journal of Pharmacology and Experimental Therapeutics January 2021, 376 (1) 147; DOI: https://doi.org/10.1124/jpet.119.261065err
You have access
Correction to “Translational Pharmacokinetic-Pharmacodynamic Modeling for an Orally Available Novel Inhibitor of Epigenetic Regulator Enhancer of Zeste Homolog 2”
Journal of Pharmacology and Experimental Therapeutics October 2020, 375 (1) 238; DOI: https://doi.org/10.1124/jpet.119.263491err
You have access
Correction to “The GPR40 Full Agonist SCO-267 Improves Liver Parameters in a Mouse Model of Nonalcoholic Fatty Liver Disease without Affecting Glucose or Body Weight”
Journal of Pharmacology and Experimental Therapeutics October 2020, 375 (1) 237; DOI: https://doi.org/10.1124/jpet.120.000046err
You have access
Correction to “(3S)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) – a Novel Cortical-Preferring Catecholamine Transmission – and Cognition-Promoting Agent”
Journal of Pharmacology and Experimental Therapeutics September 2020, 374 (3) 531-532; DOI: https://doi.org/10.1124/jpet.120.000304
You have access
Correction to “Biological Characterization of F508delCFTR Protein Processing by the CFTR Corrector ABBV-2222/GLPG2222”
Journal of Pharmacology and Experimental Therapeutics September 2020, 374 (3) 499; DOI: https://doi.org/10.1124/jpet.119.261800err
You have access
Correction to “Aripiprazole Cytotoxicity Coincides with Activation of the Unfolded Protein Response in Human Hepatic Cells”
Journal of Pharmacology and Experimental Therapeutics September 2020, 374 (3) 529; DOI: https://doi.org/10.1124/jpet.119.264481err
You have access
Correction to “A Mechanistic and Translational Pharmacokinetic-Pharmacodynamic Model of Abicipar Pegol and Vascular Endothelial Growth Factor Inhibition”
Journal of Pharmacology and Experimental Therapeutics September 2020, 374 (3) 530; DOI: https://doi.org/10.1124/jpet.120.000210

Pages